What is the price-to-earnings ratio of Sanofi?
The price-earnings ratio of Sanofi is currently 2.28.
Sanofi P/S 2024
Sanofi P/S
2.28
Sanofi Dividend yield
4.12 %
Ticker
SAN.PA
ISIN
FR0000120578
WKN
920657
As of Apr 16, 2024, Sanofi's P/S ratio stood at 2.28, a -10.24% change from the 2.54 P/S ratio recorded in the previous year.
The Sanofi P/S history
Sanofi Aktienanalyse
What does Sanofi do?
Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Sanofi's P/S Ratio
Sanofi's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Sanofi's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Sanofi's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Sanofi’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Sanofi Stock
How has the price-earnings ratio of Sanofi changed compared to last year?
The price-to-earnings ratio of Sanofi has increased by -10.24% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Sanofi high compared to other companies?
Yes, the price-to-earnings ratio of Sanofi is high compared to other companies.
How does an increase in the price-earnings ratio of Sanofi affect the company?
An increase in the price-earnings ratio of Sanofi would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Sanofi affect the company?
A decrease in the price-earnings ratio of Sanofi would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Sanofi?
Some factors that influence the price-earnings ratio of Sanofi are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Sanofi pay?
Over the past 12 months, Sanofi paid a dividend of 3.56 EUR . This corresponds to a dividend yield of about 4.12 %. For the coming 12 months, Sanofi is expected to pay a dividend of 3.76 EUR.
What is the dividend yield of Sanofi?
The current dividend yield of Sanofi is 4.12 %.
When does Sanofi pay dividends?
Sanofi pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Sanofi?
Sanofi paid dividends every year for the past 26 years.
What is the dividend of Sanofi?
For the upcoming 12 months, dividends amounting to 3.76 EUR are expected. This corresponds to a dividend yield of 4.34 %.
In which sector is Sanofi located?
Sanofi is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sanofi kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sanofi from 5/15/2024 amounting to 3.76 EUR, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.
When did Sanofi pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Sanofi in the year 2023?
In the year 2023, Sanofi distributed 3.313 EUR as dividends.
In which currency does Sanofi pay out the dividend?
The dividends of Sanofi are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sanofi stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Sanofi
Our stock analysis for Sanofi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanofi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
